JP2016527292A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016527292A5 JP2016527292A5 JP2016532347A JP2016532347A JP2016527292A5 JP 2016527292 A5 JP2016527292 A5 JP 2016527292A5 JP 2016532347 A JP2016532347 A JP 2016532347A JP 2016532347 A JP2016532347 A JP 2016532347A JP 2016527292 A5 JP2016527292 A5 JP 2016527292A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- amount
- hyaluronate
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 20
- -1 ascorbyl hyaluronate Chemical compound 0.000 claims 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 4
- 229920002674 hyaluronan Polymers 0.000 claims 4
- 229940014041 hyaluronate Drugs 0.000 claims 4
- 229960003160 hyaluronic acid Drugs 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000003974 emollient agent Substances 0.000 claims 2
- 239000003906 humectant Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 229920001059 synthetic polymer Polymers 0.000 claims 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 229960001631 carbomer Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 239000012452 mother liquor Substances 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- 229920001451 polypropylene glycol Polymers 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000006254 rheological additive Substances 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims 1
- 229940098465 tincture Drugs 0.000 claims 1
- 239000003981 vehicle Substances 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13179245.9A EP2835130A1 (en) | 2013-08-05 | 2013-08-05 | Composition for skin anti-ageing treatment |
| EP13179245.9 | 2013-08-05 | ||
| PCT/EP2014/066723 WO2015018792A1 (en) | 2013-08-05 | 2014-08-04 | Composition for skin anti-ageing treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016527292A JP2016527292A (ja) | 2016-09-08 |
| JP2016527292A5 true JP2016527292A5 (enExample) | 2017-08-24 |
Family
ID=48906184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016532347A Pending JP2016527292A (ja) | 2013-08-05 | 2014-08-04 | 皮膚抗老化処置用組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20160175241A1 (enExample) |
| EP (2) | EP2835130A1 (enExample) |
| JP (1) | JP2016527292A (enExample) |
| CN (1) | CN105555250A (enExample) |
| AR (1) | AR097216A1 (enExample) |
| AU (1) | AU2014304620A1 (enExample) |
| BR (1) | BR112016002580A2 (enExample) |
| CA (1) | CA2919771A1 (enExample) |
| HK (1) | HK1220138A1 (enExample) |
| IL (1) | IL243759A0 (enExample) |
| MX (1) | MX2016001686A (enExample) |
| TW (1) | TW201536343A (enExample) |
| UY (1) | UY35695A (enExample) |
| WO (2) | WO2015018792A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6647832B2 (ja) * | 2015-03-13 | 2020-02-14 | サントリーホールディングス株式会社 | ノンアルコールのビールテイスト飲料 |
| US9993578B1 (en) * | 2017-01-12 | 2018-06-12 | Lorstan Pharmaceutical, LLC | Silicone oil-in-water composition useful as an injectable filler and as a scaffold for collagen growth |
| CN109078220A (zh) * | 2018-08-27 | 2018-12-25 | 白晋 | 一种包含自体胶原蛋白的复合制剂及其应用 |
| CN110467689A (zh) * | 2019-09-09 | 2019-11-19 | 山东众山生物科技有限公司 | 一种透明质酸衍生物及其制备方法 |
| WO2025219934A1 (en) * | 2024-04-18 | 2025-10-23 | The Wave Innovation Group S.R.L. | Composition based on hyaluronic acid, epigallocatechin-3-o- gallate and/or xanthohumol |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3045590B2 (ja) * | 1991-12-24 | 2000-05-29 | 鐘紡株式会社 | 養毛化粧料 |
| RU2078561C1 (ru) * | 1994-04-28 | 1997-05-10 | Стекольников Леонид Ильич | Косметическое средство, предотвращающее старение кожи |
| JP3634112B2 (ja) * | 1997-03-31 | 2005-03-30 | 株式会社資生堂 | 皮膚外用剤 |
| JP3504590B2 (ja) * | 2000-06-28 | 2004-03-08 | 株式会社ノエビア | 皮膚外用剤 |
| US20030039747A1 (en) * | 2001-08-27 | 2003-02-27 | Optinel Systems,Inc. | Method of enhancing waveguide photosensitivity and waveguide having enhanced photosensitivity |
| JP2003261435A (ja) * | 2002-03-11 | 2003-09-16 | Ichimaru Pharcos Co Ltd | エネルギー変性剤 |
| JP2004035440A (ja) * | 2002-07-02 | 2004-02-05 | Ichimaru Pharcos Co Ltd | くすみ抑制剤及び肌質改善用皮膚外用剤 |
| ITMI20060122A1 (it) | 2006-01-25 | 2007-07-26 | Polichem Sa | Composizioni per uso vaginale |
| JP2008050311A (ja) * | 2006-08-25 | 2008-03-06 | Kowa Co | 使用感の良い乳化組成物 |
| DE102008014289A1 (de) * | 2008-03-11 | 2009-09-17 | Coty Prestige Lancaster Group Gmbh | Kosmetikum mit Anti-Alterungswirkung |
| JP5449626B1 (ja) * | 2012-02-15 | 2014-03-19 | Jfeスチール株式会社 | 軟窒化用鋼およびこの鋼を素材とする軟窒化部品 |
-
2013
- 2013-08-05 EP EP13179245.9A patent/EP2835130A1/en not_active Withdrawn
-
2014
- 2014-08-01 TW TW103126323A patent/TW201536343A/zh unknown
- 2014-08-04 CA CA2919771A patent/CA2919771A1/en not_active Abandoned
- 2014-08-04 CN CN201480042643.0A patent/CN105555250A/zh active Pending
- 2014-08-04 HK HK16108275.1A patent/HK1220138A1/zh unknown
- 2014-08-04 WO PCT/EP2014/066723 patent/WO2015018792A1/en not_active Ceased
- 2014-08-04 JP JP2016532347A patent/JP2016527292A/ja active Pending
- 2014-08-04 MX MX2016001686A patent/MX2016001686A/es unknown
- 2014-08-04 US US14/910,098 patent/US20160175241A1/en not_active Abandoned
- 2014-08-04 BR BR112016002580A patent/BR112016002580A2/pt not_active Application Discontinuation
- 2014-08-04 EP EP14747043.9A patent/EP3030219A1/en not_active Withdrawn
- 2014-08-04 AR ARP140102923A patent/AR097216A1/es unknown
- 2014-08-04 AU AU2014304620A patent/AU2014304620A1/en not_active Abandoned
- 2014-08-04 WO PCT/EP2014/066722 patent/WO2015018791A1/en not_active Ceased
- 2014-08-05 UY UY0001035695A patent/UY35695A/es not_active Application Discontinuation
-
2016
- 2016-01-24 IL IL243759A patent/IL243759A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4302834A3 (en) | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors | |
| JP2016527292A5 (enExample) | ||
| MX2016015179A (es) | Una formulación líquida que comprende nicotina para administracion en aerosol. | |
| EA201790568A1 (ru) | Применение двойного агониста рецепторов glp-1/глюкагона пролонгированного действия для лечения неалкогольной жировой болезни печени | |
| JP2014240439A5 (enExample) | ||
| CY1116874T1 (el) | Δοσολογικο σχημα για τη χορηγηση ενος cd19xcd3 αμφιειδικου αντισωματος | |
| AR093217A1 (es) | Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos | |
| AR068816A1 (es) | Composiciones de brimonidina mejorada para el tratamiento del eritema | |
| MY175800A (en) | Combination treatment of cancer | |
| EA201492208A1 (ru) | Композиция в водной среде, включающая по меньшей мере одну гиалуроновую кислоту и по меньшей мере одну водорастворимую соль октасульфата сахарозы | |
| NZ721500A (en) | Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury | |
| WO2015033302A3 (en) | Fulvestrant compositions | |
| EA201991679A1 (ru) | Способ получения и композиции кожного наполнителя, содержащие гиалуроновую кислоту и гидроксиапатит | |
| EP4410833A3 (en) | Compositions and methods for treating fatty tissue buildup | |
| JP2015502926A5 (enExample) | ||
| MX2021011982A (es) | Metodos y composiciones para modular la microbiota intestinal y para manejar el peso. | |
| CY1122892T1 (el) | Παραγωγα 3-(καρβοξυμεθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| MX368750B (es) | Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular. | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| MX2015006313A (es) | Composicion simbiotica y el uso de la misma. | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| MX2015003074A (es) | Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas. | |
| BR112015007592A2 (pt) | composições de enalapril | |
| MX379191B (es) | Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias e hipertension. | |
| PH12016502403B1 (en) | Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition |